Abstracts Archive - Page 2106 of 2425 - ACR Meeting Abstracts

Abstract Number: 2173 • 2013 ACR/ARHP Annual Meeting
The Interleukin-1 Receptor Antagonist Anakinra Is Effective In The Treatment Of Undifferentiated Periodic Fever Syndromes
Daniella M. Schwartz¹, Runsheng Wang², Karyl Barron³, Daniel L. Kastner⁴ and Amanda K. Ombrello⁵, ¹Rheumatology fellowship and training branch, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, ²NIH/NIAMS, Rheumatology fellowship and training branch, Bethesda, MD, ³Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, ⁴Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, ⁵National Human Genome Research Institute,National Institute of Health, Bethesda, MD
Background/Purpose: The autoinflammatory diseases are a group of disorders associated with dysregulation of the innate immune system. They are characterized by recurrent episodes of fever…
Abstract Number: 2174 • 2013 ACR/ARHP Annual Meeting
Urinalysis Monitoring In Children With Henoch-Schönlein Purpura: Is It Time To Revise?
Hao Wang¹, Manasita Tanya², Justin Hung Tiong Tan², Sook Fun Hoh³, Lena Das⁴ and Thaschawee Arkachaisri⁵, ¹Paediatrics, Duke-NUS Graduate Medical School, Singapore, Singapore, ²Rheumatology and Immunology, KK Women's and Children's Hospital, Singapore, Singapore, ³Nursing, KK Women's and Children's Hospital, Singapore, Singapore, ⁴Pediatric Rheumatology, KK Women's and Children's Hospital, Singapore, Singapore, ⁵Rheumatology & Immunology, KK Women's and Children's Hospital and Duke-NUS Graduate Medical School, Singapore, Singapore
Background/Purpose: Major complication of Henoch-Schönlein Purpura (HSP) is renal impairment. Recommended urinalysis (UA) monitoring over a period of 2 years has been a common practice…
Abstract Number: 2175 • 2013 ACR/ARHP Annual Meeting
Systematic Analysis and Pathologic Findings In Young Adults With Sudden Death Attributed To Kawasaki Disease In Childhood
Chisato Shimizu¹, Alka Sood¹, Hubert Lau¹, Steven Campman² and Jane C. Burns¹, ¹Pediatrics, UC San Diego, School of Medicine, La Jolla, CA, ²San Diego County Medical Examiner Office, La Jolla, CA
Background/Purpose: Coronary artery aneurysms (CAA) may remain silent after Kawasaki disease (KD) until adulthood when myocardial ischemia can lead to sudden death. CAA attributed to…
Abstract Number: 2177 • 2013 ACR/ARHP Annual Meeting
A Pilot Study Of Juvenile Localized Scleroderma (jLS) Consensus Treatment Plans
Suzanne C. Li¹, Kathryn S. Torok², Mara L Becker³, Fatma Dedeoglu⁴, Robert C. Fuhlbrigge⁵, Gloria C. Higgins⁶, Sandy D. Hong⁷, Maria F. Ibarra⁸, Ronald M. Laxer⁹, Thomas G. Mason II¹⁰, Elena Pope¹¹, Marilynn G. Punaro^12,13, C. Egla Rabinovich¹⁴, Katie G. Stewart¹², Christina Kelsey¹⁵, Brian Feldman¹⁶, Themba Nyrienda¹⁷ and Knut M. Wittkowski¹⁸, ¹Pediatrics, Joseph M Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack, NJ, ²Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ³Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, ⁴Division of Immunology, Boston Children's Hospital, Boston, MA, ⁵Pediatric Rheumatology, Childrens Hospital, Boston, MA, ⁶Pediatric Rheumatology Ohio State University, Nationwide Childrens Hosp, Columbus, OH, ⁷Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA, ⁸Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, ⁹Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁰Rheumatology, Mayo Clinic Rochester, Rochester, MN, ¹¹Dermatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹²Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, ¹³Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, ¹⁴Duke University Medical Center, Durham, NC, ¹⁵Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ¹⁶Rheumatology, Hospital for Sick Kids, Toronto, ON, Canada, ¹⁷Research, Hackensack University Medical Center, Hackensack, NJ, ¹⁸Center for Clinical and Translational Science, Rockefeller University, New York, NY
Background/Purpose: Purpose: To evaluate clinical assessment tools and standardized treatment regimens (consensus treatment plans, CTPs) developed for juvenile localized scleroderma (jLS) jLS is a chronic, inflammatory…
Abstract Number: 2178 • 2013 ACR/ARHP Annual Meeting
Juvenile Onset Systemic Sclerosis: Clinical and Serological Features, and Mortality In Comparison With Adult Onset Disease
Juan G. Ovalles-Bonilla¹, Francisco Javier López-Longo², Indalecio Monteagudo¹, Esperanza Naredo¹, Carlos Gonzalez Fernandez¹, María Montoro Alvarez¹, Lina Martínez-Estupiñán¹, Juan C. Nieto³, Julia Martínez-Barrio¹, Michelle Hinojosa¹, Natalia Bello¹, Belen Serrano¹, Carmen Mata¹ and Luis Carreño¹, ¹Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ²Hospital General Universitario Gregorio Marañón, Department of Rheumatology, Madrid, Spain, ³Hospital General Universitario Gregorio Marañón, Madrid, Spain
Background/Purpose: Currently data regarding long-term outcome of juvenile systemic sclerosis (jSSc) is scarce. To describe the differences between patients with jSSc versus adult onset evaluated at a single medical…
Abstract Number: 2179 • 2013 ACR/ARHP Annual Meeting
Consensus: What Agent To Use When First-Line Vasodilatadors Fail In Raynaud´s Phenomenon Or Digital Ulcers Secondary To Juvenile Systemic Sclerosis?
Marìa M. Katsicas¹, Mariana Gonzalez² and Ricardo A. G. Russo³, ¹Immunology & Rheumatology., Hospital de Pediatrìa Garrahan, Buenos Aires, Argentina, ²Immunology & Rheumatology, Hospital de Pediatría Garrahan, Buenos Aires, Argentina, ³Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina
Background/Purpose: Juvenile Systemic Sclerosis (JSS) is characterized by Raynaud`s phenomenon (RP) and digital ulcers (DU).Conventional therapy includes calcium channel blockers (CCB). A growing number of…
Abstract Number: 2180 • 2013 ACR/ARHP Annual Meeting
Presentation, Diagnosis, and Treatment Of Chronic Recurrent Multifocal Osteomyelitis
Colin Anderson¹, Erin Wylie², Travis Heare³, Jamie Stewart⁴, Kelley Capocelli⁵, Shelley Dell'Orfano³ and Jennifer Soep⁶, ¹Orthopaedic Surgery, The University of Colorado, Aurora, CO, ²Musculoskeletal Research Center, Children’s Hospital Colorado, Aurora, CO, ³Orthopaedic Surgery, Children’s Hospital Colorado, Aurora, CO, ⁴Pediatric Radiology, Children’s Hospital Colorado, Aurora, CO, ⁵Pediatric Pathology, Children’s Hospital Colorado, Aurora, CO, ⁶Pediatric Rheumatology, Children’s Hospital Colorado, Aurora, CO
Background/Purpose: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare, non-infectious inflammatory bone disorder in children. Knowledge about the disorder is limited secondary to its rare…
Abstract Number: 2181 • 2013 ACR/ARHP Annual Meeting
Methotrexate and Infliximab With Or Without Zoledronic Acid Improve Disease Activity and Prevent Damage Progression In Chronic Nonbacterial Osteomyelitis
Yongdong (Dan) Zhao¹, Nancy Chauvin², Diego Jaramillo² and Jon Burnham³, ¹Rheumatology, Children's Hospital of Philadelphia, PHILADELPHIA, PA, ²Radiology, Children's Hospital of Philadelphia, PHILADELPHIA, PA, ³Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an inflammatory bone disease that causes pain, disability, and sometimes permanent skeletal damage. MRI allows for visualization of bone…
Abstract Number: 2182 • 2013 ACR/ARHP Annual Meeting
Spectrum Of Musculoskeletal Inpatient Diagnoses At The Largest Pediatric Center In East Africa In 2011
Angela Migowa¹, Ines Colmegna², Evelyne Ng'ang'a³, John Wachira⁴, Thomas Ngwiri⁵, Carol A. Hitchon⁶, Sasha Bernatsky⁷ and Rosie Scuccimarri⁸, ¹Pediatrics, Aga Khan University Hospital, Nairobi, Kenya, ²Rheumatology, McGill University Health Centre, Montreal, QC, Canada, ³Pediatrics, University of Nairobi, Nairobi, Kenya, ⁴Pediatrics, Gertrude's Children Hospital, Nairobi, Kenya, ⁵Pediatrics, Gertrude's Children's Hospital, Nairobi, Kenya, ⁶Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ⁷Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, ⁸McGill University, Montreal, QC, Canada
Background/Purpose: Pediatric rheumatic diseases are among the most common chronic illnesses of childhood and can cause considerable disease burden and disability. The frequency and outcomes…
Abstract Number: 2183 • 2013 ACR/ARHP Annual Meeting
Spectrum Of Outpatient Musculoskeletal Visits At The Largest Pediatric Center In East Africa In 2011
Laurel Broten¹, Angela Migowa², Rosie Scuccimarri³, Evelyne Ng'ang'a⁴, John Wachira⁵, Thomas Ngwiri⁶, Sasha Bernatsky⁷, Carol A. Hitchon⁸ and Ines Colmegna⁹, ¹Rheumatology, McGill University, Montreal, QC, Canada, ²Pediatrics, Aga Khan University Hospital, Nairobi, Kenya, ³McGill University, Montreal, QC, Canada, ⁴Pediatrics, University of Nairobi, Nairobi, Kenya, ⁵Pediatrics, Gertrude's Children Hospital, Nairobi, Kenya, ⁶Pediatrics, Gertrude's Children's Hospital, Nairobi, Kenya, ⁷Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, ⁸Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ⁹Rheumatology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Pediatric rheumatic diseases are a major cause of morbidity, frequently leading to permanent disability, impaired functional status and quality of life, and significant direct…
Abstract Number: 2184 • 2013 ACR/ARHP Annual Meeting
Application Of The Bonexpert Method For Bone Age and Bone Health Assessment In Patients With Juvenile Idiopathic Arthritis
Charlotte M. Nusman¹, Janneke Anink², Lisette W.A. van Suijlekom-Smit², Marion A.J. van Rossum³, Mario Maas⁴ and Rick R. van Rijn⁴, ¹Department of Radiology, Academic Medical Center, Amsterdam, Netherlands, ²Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands, ³Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center and Reade Institute, Amsterdam, Netherlands, ⁴Radiology, Academic Medical Center, Amsterdam, Netherlands
Background/Purpose: Both the maturation of bone and its mineral density are affected by chronic inflammation in juvenile idiopathic arthritis (JIA). Bone age is in most…
Abstract Number: 2185 • 2013 ACR/ARHP Annual Meeting
Three Middle Finger Width Correlates With Maximum Mouth Opening and Is a New Reliable Parameter To Identify Joint Hypermobility In Schoolchildren
Francesca Sperotto¹, Gabriella La Falce², Fabio Vittadello¹, Lorenzo Favero² and Francesco Zulian³, ¹Department of Pediatrics, University of Padua, Padua, Italy, ²Gnatology Unit, Department of Dentistry, Padua, Italy, ³PRINTO, Genoa, Italy
Background/Purpose: Maximum mouth opening (MMO) is a useful parameter to identify common temporomandibular joint (TMJ) disorders. Up to now, a few studies addressed the issue…
Abstract Number: 2186 • 2013 ACR/ARHP Annual Meeting
Lower Extremity Strength Is Related To Diminished Quality Of Life In Obese Children
Sharon M. Bout-Tabaku^1,2, Matt Briggs³, Tom Best², Colleen Spees², Ajit Chaudhari² and Laura Schmitt⁴, ¹Rheumatology, Nationwide Children's Hospital, Columbus, OH, ²The Ohio State University, Columbus, OH, ³School of Health and Rehabilitation Sciences, Division of Physical Therapy, The Ohio State University, Columbus, OH, ⁴Health and Rehabilitation Science, The Ohio State Universtiy, Columbus, OH
Background/Purpose: Obese children have a higher prevalence of lower extremity (LE) pain, with associated diminished quality of life, greater knee malalignment, generate less knee extensor…
Abstract Number: 2187 • 2013 ACR/ARHP Annual Meeting
Inter-Rater Reliability Of Jumping Mechanography In Healthy Children and Adults
Johannes Roth¹, Ciaran M. Duffy², Tania Bennett¹, Marta Erlandson³, Michele Gibbon⁴, Heather Macdonald⁵, Douglas Race⁶, Leanne M. Ward¹ and Lori B. Tucker⁷, ¹University of Ottawa, Ottawa, ON, Canada, ²Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁵The University of British Columbia, Vancouver, BC, Canada, ⁶University of British Columbia, Vancouver, BC, Canada, ⁷Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Muscle function can be affected by many chronic disorders of childhood including Juvenile Idiopathic Arthritis (JIA). Whereas the term “muscle strength” is often used…
Abstract Number: 2188 • 2013 ACR/ARHP Annual Meeting
Role of Interleukin-1 in Abnormal Monocyte Phenotype in Systemic Onset Juvenile Idiopathic Arthritis
Yujuan Zhang^1,2, Claudia Macaubas², Clarissa Klein³, M. Virginia Pascual⁴, Arielle Hay⁵, Susan D. Thompson⁶, Christy I. Sandborg³, Norman T. Ilowite⁷ and Elizabeth D. Mellins⁸, ¹Pediatrics, Stanford University Med Ctr, Palo Alto, CA, ²Pediatric Rheumatology, Stanford University Med Ctr, Stanford, CA, ³Stanford University Med Ctr, Stanford, CA, ⁴Baylor Institue for Immunology Research, Dallas, TX, ⁵The Children's Hospital at Montefiore, Bronx, NY, ⁶Department of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁷Pediatrics, The Children's Hospital at Montefiore, Bronx, NY, ⁸Dept of Pediatrics CCSR, Stanford University Medical Center, Stanford, CA
Background/Purpose: Monocytes undergo phenotype changes when exposed to different microenvironments: the classic proinflammatory M1 phenotype, alternative regulatory M2 phenotype and M2-like phenotype, are each regulated…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].